Fresenius Medical Care AG & Co. KGaA ( ETR:FME ) came out with its full-year results last week, and we wanted to see...
Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.